Literature DB >> 33847784

Hepatic artery resection and reconstruction using the right gastroepiploic artery during pancreaticoduodenectomy in advanced pancreatic cancer.

Yoshitaro Shindo1, Yukio Tokumitsu1, Satoshi Matsukuma1, Hiroto Matsui1, Masao Nakajima1, Nobuaki Suzuki1, Shigeru Takeda1, Yoshinobu Hoshii2, Hiroaki Nagano3.   

Abstract

PURPOSE: Surgical resection is the only curative treatment for pancreatic cancer. Arterial resection and reconstruction during pancreaticoduodenectomy for advanced pancreatic cancer remain controversial due to a high rate of complications.
METHODS: We report two cases of pancreatic cancer with hepatic artery resection and reconstruction using the right gastroepiploic artery during pancreaticoduodenectomy after neoadjuvant therapy.
RESULTS: The patients underwent pancreaticoduodenectomy with resection of the right hepatic and common hepatic arteries. Achieving direct anastomosis was difficult; therefore, we planned hepatic artery reconstruction using the right gastroepiploic artery. We performed the reconstruction using an interrupted suture with end-to-end anastomosis. The first patient developed a postoperative pancreatic fistula, while the postoperative course of the second patient was uneventful. However, there were no adverse events related to the arterial reconstruction. R0 resection was achieved, and postoperative computed tomography revealed good patency of the reconstructed artery.
CONCLUSION: Hepatic artery reconstruction using the right gastroepiploic artery in pancreatic cancer might be technically safe and might become one of the alternative options.

Entities:  

Keywords:  Hepatic artery reconstruction; Hepatic artery resection; Pancreatic cancer; Pancreaticoduodenectomy; Right gastroepiploic artery

Year:  2021        PMID: 33847784     DOI: 10.1007/s00423-021-02120-0

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  22 in total

1.  Portal or superior mesenteric vein resection in pancreatoduodenectomy for pancreatic head carcinoma.

Authors:  Y Murakami; S Satoi; F Motoi; M Sho; M Kawai; I Matsumoto; G Honda
Journal:  Br J Surg       Date:  2015-04-15       Impact factor: 6.939

Review 2.  Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis.

Authors:  Nathan Mollberg; Nuh N Rahbari; Moritz Koch; Werner Hartwig; Yumiko Hoeger; Markus W Büchler; Jürgen Weitz
Journal:  Ann Surg       Date:  2011-12       Impact factor: 12.969

3.  Hepatic artery reconstruction in living donor liver transplantation: risk factor analysis of complication and a role of MDCT scan for detecting anastomotic stricture.

Authors:  Shigeru Marubashi; Shogo Kobayashi; Hiroshi Wada; Koichi Kawamoto; Hidetoshi Eguchi; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

4.  A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer.

Authors:  Thomas J Howard; Joseph E Krug; Jian Yu; Nick J Zyromski; C Max Schmidt; Lewis E Jacobson; James A Madura; Eric A Wiebke; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2006-12       Impact factor: 3.452

5.  Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study.

Authors:  Reena Ravikumar; Caroline Sabin; Mohammad Abu Hilal; Simon Bramhall; Steven White; Stephen Wigmore; Charles J Imber; Giuseppe Fusai
Journal:  J Am Coll Surg       Date:  2013-11-27       Impact factor: 6.113

6.  Arterial en bloc resection for pancreatic carcinoma.

Authors:  M Bockhorn; C Burdelski; D Bogoevski; G Sgourakis; E F Yekebas; J R Izbicki
Journal:  Br J Surg       Date:  2010-10-25       Impact factor: 6.939

7.  Pancreatectomy with vein reconstruction: technique matters.

Authors:  Monica M Dua; Thuy B Tran; Jill Klausner; Kim J Hwa; George A Poultsides; Jeffrey A Norton; Brendan C Visser
Journal:  HPB (Oxford)       Date:  2015-07-30       Impact factor: 3.647

8.  International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017.

Authors:  Shuji Isaji; Shugo Mizuno; John A Windsor; Claudio Bassi; Carlos Fernández-Del Castillo; Thilo Hackert; Aoi Hayasaki; Matthew H G Katz; Sun-Whe Kim; Masashi Kishiwada; Hirohisa Kitagawa; Christoph W Michalski; Christopher L Wolfgang
Journal:  Pancreatology       Date:  2017-11-22       Impact factor: 3.996

9.  Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy.

Authors:  Hiroto Matsui; Shoichi Hazama; Kazuhiko Sakamoto; Yoshitaro Shindo; Shinsuke Kanekiyo; Masao Nakashima; Satoshi Matsukuma; Yoshihiro Tokuhisa; Michihisa Iida; Nobuaki Suzuki; Kiyoshi Yoshimura; Shigeru Takeda; Tomio Ueno; Shigefumi Yoshino; Masaaki Oka; Hiroaki Nagano
Journal:  Pancreas       Date:  2017-09       Impact factor: 3.327

10.  Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.

Authors:  Yoshitaro Shindo; Shoichi Hazama; Nobuaki Suzuki; Haruo Iguchi; Kazuhiro Uesugi; Hiroaki Tanaka; Atsushi Aruga; Takashi Hatori; Hidenobu Ishizaki; Yuzo Umeda; Toshiyoshi Fujiwara; Tetsuya Ikemoto; Mitsuo Shimada; Kazuhiko Yoshimatsu; Hiroko Takenouchi; Hiroto Matsui; Shinsuke Kanekiyo; Michihisa Iida; Yasunobu Koki; Hideki Arima; Hiroyuki Furukawa; Tomio Ueno; Shigefumi Yoshino; Tomonobu Fujita; Yutaka Kawakami; Yusuke Nakamura; Masaaki Oka; Hiroaki Nagano
Journal:  J Exp Clin Cancer Res       Date:  2017-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.